Evidence map›Paper›PMID 32416925›Full record

GuidelineBulletin du cancer2020

[Breast cancer screening and diagnosis at the end of the COVID-19 confinement period, practical aspects and prioritization rules: recommendations of 6 French health professionals societies].

Luc Ceugnart, Suzette Delaloge, Corinne Balleyguier, Michel Deghaye, Lucie Veron, Aldis Kaufmanis, Audrey Mailliez, Edouard Poncelet, Gregory Lenczner, Laurent Verzaux and 2 more

Abstract readPractice Guideline
In one paragraph

Guideline in Bulletin du cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Luc CeugnartDépartement d'imagerie médicale, centre Oscar-Lambret, Lille, France.
Suzette DelalogeDépartement de médecine oncologique et prévention des cancers, Gustave-Roussy, Villejuif, France. Electronic address: suzette.delaloge@gustaveroussy.fr.
Corinne BalleyguierDépartement d'imagerie, Gustave-Roussy, Villejuif, France.
Michel DeghayeCentre régional de coordination des dépistages des cancers d'Ile de France, Paris, France.
Lucie VeronDépartement de médecine oncologique et prévention des cancers, Gustave-Roussy, Villejuif, France.
Aldis KaufmanisCentre régional de coordination des dépistages des cancers d'Ile de France, Paris, France.
Audrey MailliezDépartement d'oncologie médicale et génétique, centre Oscar-Lambret, Lille, France.
Edouard PonceletService d'imagerie de la femme, centre hospitalier de Valenciennes, Valenciennes, France.
Gregory LencznerRadiologie Paris-Ouest, Levallois-Perret, France.
Laurent VerzauxService de radiologie clinique Les Ormeaux, Le Havre, France.
Joseph GligorovDépartement d'oncologie médicale, hôpital Tenon, Paris, France.
Isabelle Thomassin-NaggaraDépartement d'Imagerie médicale, hôpital Tenon, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusPandemicsQuarantineAge FactorsBreast NeoplasmsCoronavirus InfectionsCOVID-19Delivery of Health CareFemaleFranceHealth PrioritiesHumansHygieneMass ScreeningPersonal SpacePneumonia, ViralBreastCOVID-19DépistageDiagnosisDiagnosticScreeningSein

Identifiers

PMID32416925
PMCPMC7203044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.